Vanderbilt Therapeutics CRS — Nashville, Tennessee

Vanderbilt Therapeutics CRS is a clinical research site located in Nashville, Tennessee, United States 37203.

Crixeo Health Trust Score: 75/100 (FAIR). This profile has not yet been claimed by the site owner.

Vanderbilt Therapeutics CRS has participated in 22 clinical trials.

Therapeutic areas: HIV Infections, HIV I Infection, HIV Infection.

Sponsors: National Institute of Allergy and Infectious Diseases (NIAID), Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections.

Sponsor Feasibility Report

Trust Score: 75/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Vanderbilt Therapeutics CRS?

Vanderbilt Therapeutics CRS has a Crixeo Trust Score of 75/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Vanderbilt Therapeutics CRS conducted?

Vanderbilt Therapeutics CRS has 22 clinical trials on record. Their work covers HIV Infections, HIV I Infection, HIV Infection.

Is Vanderbilt Therapeutics CRS accredited by Crixeo Health?

Vanderbilt Therapeutics CRS has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Vanderbilt Therapeutics CRS?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.